Industry Impacts Of COVID-19: Are Vaccine Mandates A Legal Solution?
Executive Summary
The coronavirus pandemic is still raging but it is clear that higher vaccination rates worldwide will help the life sciences sector return to a semblance of normality. Lincoln Tsang, Julie Kvedar, and William Radcliffe of Ropes & Gray LLP consider the impact of the COVID-19 pandemic on the industry and the legal issues raised by mandatory vaccination in certain key geographical regions.
You may also be interested in...
Mosie Baby Wins FDA Clearance For First At-Home DYI Artificial Insemination Kit
Austin-based start-up Mosie received FDA clearance for a home insemination kit to help people get pregnant. The kit retails for $129.99.
Unilever Squelches Dr. Squatch Comparative Claims In NAD Forum; Advertiser Can Keep Its 'Sh*t List’
Dr. Squatch was able to substantiate that it uses “no harmful ingredients” as well as certain claims about avoiding a “Sh*t list” of ingredients, but agreed to modify other claims the National Advertising Division deemed falsely disparage competitor products, such as Unilever’s Dove personal-care brand.
Pharvaris’s Oral HAE Prevention Data May Threaten BioCryst’s Orladeyo
The Swiss firm reported that its oral bradykinin B2 receptor antagonist reduced monthly hereditary angioedema attacks by 84.5% compared with placebo, suggesting biologic-like efficacy with an oral drug.